BB-031
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BB-031, covering 2026-03-18 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of BB-025, Alone and After BB-031, in Healthy Volunteers [Phase 1]